WASHINGTON, Nov. 12,
2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc.
(Vanda) (Nasdaq: VNDA) today announced that the company will
participate in the following upcoming investor conferences in
November 2024:
The Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024. A corporate
presentation is scheduled for 9:45 a.m.
Eastern Time.
The Jefferies 2024 London Healthcare Conference on Thursday, November 21, 2024. A fireside chat is
scheduled for 11:30 a.m. Greenwich
Mean Time (6:30 a.m. Eastern
Time).
The corporate presentation and fireside chat given at the Stifel
and Jefferies conferences, respectively, may be accessed live on
Vanda's corporate website, www.vandapharma.com. Investors should
click on the Investors tab and follow the links under Recent
Events. Investors are advised to go to the conference websites at
least 15 minutes early to register, download, and install any
necessary software or presentations. Links to the archived
conferences will be available on Vanda's website for a period of
approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin
Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan
Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2024-investor-conferences-302303384.html
SOURCE Vanda Pharmaceuticals Inc.